Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.92
-0.33 (-1.55%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $80.09 million as of September 29, 2026. Its market cap has decreased by -22.11% in one year.
Market Cap
80.09M
Enterprise Value
129.01M
1-Year Change
-22.11%
Ranking
Category
Stock Price
$20.92
ChartMarket Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $80.09M, an increase of 189.31%. That is a compound annual growth rate of 50.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 80.09M | -16.30% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 89.24M |
| Acrivon Therapeutics | 88.28M |
| Oncolytics Biotech | 84.54M |
| Atara Biotherapeutics | 84.02M |
| Telomir Pharmaceuticals | 82.53M |
| Verrica Pharmaceuticals | 79.02M |
| NeOnc Technologies Holdings | 78.55M |
| Gain Therapeutics | 77.25M |